Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Zauner

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Science Advances|June 24, 2026
Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinomaGiorgia Nasi, Leonie C Schöftner, Lara Ronacher, et al.
International Journal of Molecular Sciences|April 3, 2021
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis BullosaMichael Ablinger, Thomas Lettner, Nicole Friedl, et al.
The Journal of Investigative Dermatology|December 6, 2017
Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell CarcinomaYuchen Sun, Katharina Woess, Melanie Kienzl, et al.
The British Journal of Dermatology|September 8, 2023
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomasJulia Illmer, Roland Zauner, Josefina Piñón Hofbauer, et al.
Cell Communication and Signaling : CCS|April 12, 2020
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomasMonika Wimmer, Roland Zauner, Michael Ablinger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosaMarkus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
The Journal of Experimental Medicine|February 20, 2025
HMCN1 variants aggravate epidermolysis bullosa simplex phenotypeShir Bergson, Ofer Sarig, Moshe Giladi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Science Advances|June 24, 2026
Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinomaGiorgia Nasi, Leonie C Schöftner, Lara Ronacher, et al.
International Journal of Molecular Sciences|April 3, 2021
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis BullosaMichael Ablinger, Thomas Lettner, Nicole Friedl, et al.
The Journal of Investigative Dermatology|December 6, 2017
Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell CarcinomaYuchen Sun, Katharina Woess, Melanie Kienzl, et al.
The British Journal of Dermatology|September 8, 2023
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomasJulia Illmer, Roland Zauner, Josefina Piñón Hofbauer, et al.
Cell Communication and Signaling : CCS|April 12, 2020
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomasMonika Wimmer, Roland Zauner, Michael Ablinger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosaMarkus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
The Journal of Experimental Medicine|February 20, 2025
HMCN1 variants aggravate epidermolysis bullosa simplex phenotypeShir Bergson, Ofer Sarig, Moshe Giladi, et al.
Pageof 2